Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuki Sasaki
Institution:
Tokyo Metropolitan Komagome Hospital
Observed institution:
Tokyo Metropolitan Komagome Hospital
ORCID:
0000-0001-5741-507X
Observed ORCID:
0000-0001-5741-507X
OpenAlex ID:
A5080764443
Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma
2018
·
Yusuke Kanemasa
, Tatsu Shimoyama
, et al.
·
Annals of Hematology
·
70
Beta‐2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B‐cell lymphoma
2016
·
Yusuke Kanemasa
, Tatsu Shimoyama
, et al.
·
Hematological Oncology
·
45
Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B‐cell lymphoma
2020
·
Akihito Nagata
, Yusuke Kanemasa
, et al.
·
Hematological Oncology
·
39
Central nervous system relapse in patients with diffuse large B cell lymphoma: analysis of the risk factors and proposal of a new prognostic model
2016
·
Yusuke Kanemasa
, Tatsu Shimoyama
, et al.
·
Annals of Hematology
·
32
The impacts of initial and relative dose intensity of R-CHOP on outcomes of elderly patients with diffuse large B-cell lymphoma
2016
·
Yusuke Kanemasa
, Tatsu Shimoyama
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
17
A new prognostic score comprising lactate dehydrogenase, albumin and neutrophil to lymphocyte ratio to predict sensitivity to first-line chemotherapy in patients with peripheral T-cell lymphomas
2017
·
Satoshi Kaito
, Yusuke Kanemasa
, et al.
·
International Journal of Hematology
·
13
Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma
2023
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
Annals of Hematology
·
11
Analysis of prognostic value of complete response by PET–CT and further stratification by clinical and biological markers in DLBCL patients
2017
·
Yusuke Kanemasa
, Tatsu Shimoyama
, et al.
·
Medical Oncology
·
11
Analysis of the prognostic value of BMI and the difference in its impact according to age and sex in DLBCL patients
2017
·
Yusuke Kanemasa
, Tatsu Shimoyama
, et al.
·
Hematological Oncology
·
10
Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study
2022
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
BMC Cancer
·
9
PDF
A convenient prognostic score consisting of the Glasgow prognostic score and serum lactate dehydrogenase predicts clinical outcome in patients with diffuse large B-cell lymphoma
2016
·
Yusuke Kanemasa
, Tatsu Shimoyama
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
6
Impact of pegfilgrastim approval on relative dose intensity and outcomes of R-CHOP for diffuse large B-cell lymphoma
2022
·
Yuka Morita
, Yusuke Kanemasa
, et al.
·
Medicine
·
5
[Tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma: real-world data from single institute experience].
2022
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
PubMed
·
4
Hemoglobin‐platelet index as a prognostic factor in patients with peripheral T‐cell lymphoma
2023
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
eJHaem
·
3
PDF
Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy
2024
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
Journal of the Japan Society of the Reticuloendothelial System
·
2
[Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant].
2023
·
Yuka Morita
, Yu Yagi
, et al.
·
PubMed
·
1
Prognostic significance of CD30 expression in patients with diffuse large B-cell lymphoma
2017
·
Yusuke Kanemasa
, Tatsu Shimoyama
, et al.
·
Annals of Oncology
·
1
Outcome Analysis of DLBCL in HIV-infected and non-HIV-infected patients
2016
·
Yusuke Kanemasa
, Tatsu Shimoyama
, et al.
·
Annals of Oncology
·
1
PDF
Author response for "Clinical impact of Controlling Nutritional Status (CONUT) score on the prognosis of patients with diffuse large B-cell lymphoma"
2020
·
Akihito Nagata
, Yusuke Kanemasa
, et al.
·
Publons reviews and discussion
Central nervous system relapse in diffuse large B-cell lymphoma: analysis of risk factors and a new prognostic model
2015
·
Yusuke Kanemasa
, Tatsu Shimoyama
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
20
Citation count:
280
H-index:
9
I10-index:
9
Year
Topic
Type